Alzamend Neuro's total assets for Q were $782.64K, a decrease of -20.43% from the previous quarter. ALZN total liabilities were $4.57M for the fiscal quarter, a 24.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.